Asymchem Life Science (Tianjin) Co., Ltd.March 21, 2025

FDA 483 - Asymchem Life Science (Tianjin) Co., Ltd. - March 21, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Asymchem Life Science (Tianjin) Co., Ltd.

Record Details

An FDA inspection of Asymchem Life Science (Tianjin) Co., Ltd., a drug manufacturer, revealed significant deficiencies in quality control and data integrity. The firm failed to thoroughly review manufacturing discrepancies, maintain written procedures for its quality control unit, and implement adequate controls over computer systems for data backup. These issues indicate a lack of robust oversight in critical manufacturing and data management processes.

Company: Asymchem Life Science (Tianjin) Co., Ltd.
Inspection Date: March 21, 2025
Product Type: Drugs
Office: Office of Inspections and Investigations
Person: Dipesh K. Shah

Open in Dashboard

ID · 8e8cadb8-b4b3-41ec-b18a-c6dc65612ef8